comparemela.com

Latest Breaking News On - Analyst recommendations for madrigal pharmaceuticals - Page 2 : comparemela.com

Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL) Receives $356 73 Average Price Target from Analysts

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.